EU | pharmaphorum

EU

News

Industry steps up as EU debates an action plan for AI

Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.

News

INTERCEPT trial team at a meeting in Vienna

Takeda backs biomarker trial for Crohn's prevention

The INTERCEPT trial aims to validate biomarkers that could identify people at risk of Crohn's and see if treatment can prevent symptoms developing.

News

EU approves endometrial, lung cancer drugs from GSK and J&J

Both GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies in the EU.

News

EU pharma calls for speedy shift to digital package inserts

Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.

News

Court sides with EU on decision to revoke Ocaliva's license

Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure

News

Sanofi to invest €1bn in France to lift ‘health sovereignty’

Sanofi will invest more than €1 billion ($1.08 billion) in new bioproduction capacity at three manufacturing sites in France as part of a €3.5 billion programme in the cou

Industry steps up as EU debates an action plan for AI

Takeda backs biomarker trial for Crohn's prevention

EU approves endometrial, lung cancer drugs from GSK and J&J

EU pharma calls for speedy shift to digital package inserts

Court sides with EU on decision to revoke Ocaliva's license

Sanofi to invest €1bn in France to lift ‘health sovereignty’

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

EU

Editor's Picks